Press release
Acne Therapeutics Market 2025 | Key Investments, FDA Approvals, Global Player Expansion - Reckitt Benckiser Group, Stiefel Laboratories, Valeant Pharmaceuticals, Allergan Plc, Bausch Health Companies Inc
Acne Therapeutics Market
DataM Intelligence has published a new research report on "Acne Therapeutics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/acne-therapeutics-market?kb
Latest M&A Activity
Dermatology-focused M&A has shown increasing activity in 2025, with companies acquiring innovative biotech firms developing novel acne therapies and expanding their dermatology portfolios to capture greater market share.
Leading pharmaceutical and dermatology companies like Galderma, Allergan, Johnson & Johnson, and Bausch Health continue strategic acquisitions and collaborations focused on biosynthetic and receptor inhibitor acne treatments
Key Players:
Allergan Plc, Galderma S.A, Bausch Health Companies Inc, Sun Pharmaceutical Industries Ltd, Johnson & Johnson, Reckitt Benckiser Group, Stiefel Laboratories, Valeant Pharmaceuticals, Teva Pharmaceuticals, Cutera Inc
Key Development:
August 2025: Alembic Pharmaceuticals received FDA approval to launch Tretinoin Cream USP 0.025% in the US, a generic equivalent of Retin-A Cream 0.025%, for the topical treatment of acne vulgaris.
July 2025:
Hyphens Pharma introduced Winlevi (clascoterone) cream 1% in Singapore and Malaysia, marking its Southeast Asian debut.
Sagimet Biosciences announced that denifanstat, an oral FASN inhibitor, met all primary and secondary endpoints in a Phase 3 trial for moderate-to-severe acne vulgaris in China. Sagimet also began a Phase 1 trial for a second FASN inhibitor, TVB-3567, in the US.
Cosmo Pharmaceuticals, in partnership with Hyphens Pharma, launched Winlevi 1% cream in Singapore and Malaysia for patients aged 12 and older.
April 2025: Sonoma Pharmaceuticals, Inc. registered its hypochlorous acid-based acne products with the UK's MHRA. Developed using Microcyn technology, these products target dermatological, wound care, and eye care applications and will be sold through a UK health and beauty retailer and pharmacy chain.
March 2025: Dermata Therapeutics, Inc. reported positive Phase 3 results for XYNGARI, a once-weekly topical treatment for moderate-to-severe acne. The product was safe, well-tolerated, and showed minimal treatment-related adverse events with no serious safety concerns.
Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/acne-therapeutics-market?kb
Growth Forecast Projected:
The Global Acne Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Acne Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=acne-therapeutics-market?kb
Key Segments:
by Therapeutics: (Retinoids, Antibiotics, Hormonal Agents, Anti-inflammatory Agents, Others)
by Route of Administration: (Oral, Injectables)
by Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Regulatory and FDA Approvals
Cosmo Pharmaceuticals received regulatory approval in October 2025 from the European Commission for Winlevi® (clascoterone 1% cream), the first topical anti-androgen acne therapy approved for use in adults and adolescents aged 12 to
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acne Therapeutics Market 2025 | Key Investments, FDA Approvals, Global Player Expansion - Reckitt Benckiser Group, Stiefel Laboratories, Valeant Pharmaceuticals, Allergan Plc, Bausch Health Companies Inc here
News-ID: 4234617 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Chronic Disease Management Market Growth Driven by Rising Prevalence of Diabetes …
The Global Chronic Disease Management Market was valued at US$ 4.8 billion in 2022 and is projected to grow to US$ 14.6 billion by 2031, with a compound annual growth rate (CAGR) of 11.4% from 2024 to 2031.
This growth is attributed to the rising number of chronic diseases like cardiovascular disorders, diabetes, and respiratory conditions, as well as an increasing elderly population globally. The use of digital health solutions,…
United States Gene Prediction Tools Market Opportunities in Drug Discovery and D …
"The Global gene prediction tool market is expected to reach at a CAGR 18.5% during the forecast period 2024-2031. According to DataM intelligence Report.
Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):
https://www.datamintelligence.com/download-sample/gene-prediction-tool-market?oppratik
United States: Recent Industry Developments:
✅ October 15, 2025: Illumina launched its novel 5-base solution at the ASHG conference in the US, enabling simultaneous detection of genomic variants and DNA methylation for rare disease research…
Centrifugal Compressors Market Trends 2025 | Emerging Applications in HVAC & Ind …
DataM Intelligence has published a new research report on "Centrifugal Compressors Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report…
Agrochemicals Market 2025, M&A & Investment Trends to hit USD 3,38,727.15 millio …
Agrochemicals Market size was worth USD 2,51,345.54 million in 2024 and is estimated to reach USD 3,38,727.15 million by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032)
DataM Intelligence has published a new research report on "Agrochemicals Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
